Tim Perera
Impact in
- Hepatology top 10%
- Liver physiology and pathology
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 4
- HER2/EGFR in Cancer Research 4
- Cytokine Signaling Pathways and Interactions 1
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Peter King (3 shared papers)Paolo M. Comoglio (2 shared papers)Silvia Giordano (2 shared papers)J. Rafael Sierra (2 shared papers)Simona Corso (2 shared papers)Virna Cepero (2 shared papers)Elena Ghiso (2 shared papers)Laura Casorzo (2 shared papers)
- Journals
- Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)PLoS Biology (1 paper)Annals of Oncology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- ItalyUnited KingdomBelgium
In The Last Decade
Tim Perera
7 papers receiving 290 citations
Peers
Comparison fields: 5 of 45
- Hepatology 72
- Oncology 145
- Immunology and Allergy 22
- Radiology, Nuclear Medicine and Imaging 76
- Pulmonary and Respiratory Medicine 77
Countries citing papers authored by Tim Perera
This map shows the geographic impact of Tim Perera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Perera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Perera more than expected).
Fields of papers citing papers by Tim Perera
This network shows the impact of papers produced by Tim Perera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Perera. The network helps show where Tim Perera may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Perera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 141 | |
| 2 | 2010 | 109 | |
| 3 | 2009 | 33 | |
| 4 | 2010 | 6 | |
| 5 | 2010 | 4 | |
| 6 | UPREGULATION OF ADAM17 PROTEASE AND HER LIGANDS THROUGH A PKB NEGATIVE FEEDBACK LOOP MEDIATES ACQUIRED RESISTANCE TO TRASTUZUMAB IN HER2 OVEREXPRESSED BREAST CANCER | 2010 | 3 |
| 7 | 2024 | 1 | |
| 8 | 2006 | 1 |
About Tim Perera
Tim Perera is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Hepatology and Molecular Biology, having authored 8 papers that have together received 298 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Liver physiology and pathology (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Hepatology (72 citations), Oncology (145 citations), Immunology and Allergy (22 citations), Radiology, Nuclear Medicine and Imaging (76 citations) and Pulmonary and Respiratory Medicine (77 citations). Tim Perera has collaborated with scholars based in Italy, United Kingdom and Belgium. Frequent co-authors include Peter King, Paolo M. Comoglio, Silvia Giordano, J. Rafael Sierra, Simona Corso, Virna Cepero, Elena Ghiso, Laura Casorzo, Merel Gijsen and Peter J. Parker. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, PLoS Biology, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.